ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• It's Official: CRIO Sites Are Now 25% Of US Sites On Chronic Condition Studies

  CRIO continues to lead the U.S. eSource market, with its platform widely adopted across clinical research sites. A recent analysis of 50 Phase 2 and 3 studies showed that, on average, 28% of U.S. sites were CRIO clients, with even higher adoption in key therapeutic areas.

• Reframing Clinical Vendor Selection

  Explore a platform that enables seamless vendor selection as well as cross-functional collaboration with built-in templates and tailored question libraries that simplify proposal creation and review.

• GSK And Medable Discuss The Next Phase Of DCTs

  GSK and Medable share the value of embedding DCTs into strategic goals to enhance trial accessibility, diversity, and efficiency.

• 5 Benefits Of Using A Study Management Tool

  See how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.

• Implementing ICH E6 (R3) In A Risk Averse Culture

  Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.

• Customizing EDC Workflows For Specialty Pharma, Rare Disease Trials

  Rare disease and specialty pharma trials demand a level of flexibility with electronic data capture systems that can adapt dynamically without sacrificing data integrity.

• Choosing The Right eClinRO Solution For Reliable Trial Data

  Electronic clinician-reported outcomes (eClinROs) enhance the quality and consistency of clinical trial data. Discover key factors to consider when selecting an eClinRO provider.

• Paving The Way For Virtual Trials In Neurology: A Fully Remote ALS Study

  The COVID-19 pandemic has completely changed the way we think about clinical research and care. Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites.

• Shaping The Future Of Clinical Trial Technology With tPlatform Unification

  As we look toward 2026, the conversation around clinical trial technology is shifting from simple digitization to true platform unification.

• Why Scalable EDC Systems Matter In Global Pharmaceutical Trials

  Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.